Corrections Noted in Table 2 of the Melanoma Self Surveillance Trial Article
-
May 1, 2026
Original Source(s)
Related Content
Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer
by Chuan Angel Lu, Changchuan Jiang, Andrew Z. Wang, Tian Zhang
May 29, 2026
Long-term survival with stereotactic radiosurgery and 100+ cycles of Keytruda in a patient with brain metastases from melanoma
by Darrah Sheehan, Kimball Sheehan, Yuki Shinya, Camilo E. Fadul
June 18, 2026
Engineering CAR T Cells to Resist Tumor Immune Suppression
CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models
March 9, 2026
-
2 min
